Berkowitz R S, Im S S, Bernstein M R, Goldstein D P
New England Trophoblastic Disease Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
J Reprod Med. 1998 Jan;43(1):81-6.
To determine subsequent reproductive outcomes in patients treated for partial molar pregnancy, complete molar pregnancy and persistent gestational trophoblastic tumors at the New England Trophoblastic Disease Center (NETDC) between June 1, 1965, and December 31, 1996.
Questionnaires were mailed to all patients followed at the NETDC to assess subsequent pregnancy experience. All patients and their referring physicians were also requested to inform the NETDC about later pregnancies.
Following partial mole, complete mole and persistent gestational trophoblastic tumor, our patients had 195, 1,234 and 504 later pregnancies, respectively. These patients had a later pregnancy experience comparable to that of the general population. However, after having one molar pregnancy, the risk of molar pregnancy in a later conception was about 1%. Twenty-nine of our patients had at least two episodes of molar pregnancy; following two episodes of molar pregnancy, 6 (23.1%) of 26 later conceptions resulted in another molar gestation.
Patients with partial mole, complete mole and persistent gestational trophoblastic tumor can be reassured that in general they can anticipate a normal future reproductive outcome.
确定1965年6月1日至1996年12月31日期间在新英格兰滋养细胞疾病中心(NETDC)接受部分性葡萄胎、完全性葡萄胎和持续性妊娠滋养细胞肿瘤治疗的患者的后续生殖结局。
向NETDC随访的所有患者邮寄问卷,以评估其后续妊娠经历。还要求所有患者及其转诊医生向NETDC通报后来的妊娠情况。
部分性葡萄胎、完全性葡萄胎和持续性妊娠滋养细胞肿瘤患者后续妊娠次数分别为195次、1234次和504次。这些患者的后续妊娠经历与普通人群相当。然而,有过一次葡萄胎妊娠后,再次妊娠时发生葡萄胎妊娠的风险约为1%。我们的患者中有29人至少有两次葡萄胎妊娠;在两次葡萄胎妊娠后,26次后续妊娠中有6次(23.1%)再次发生葡萄胎妊娠。
部分性葡萄胎、完全性葡萄胎和持续性妊娠滋养细胞肿瘤患者一般可以放心,他们未来的生殖结局通常是正常的。